Variant report
Variant | nsv5396 |
---|---|
Chromosome Location | chr6:93653199-93698107 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:93626953..93629918-chr6:93651700..93654036,3 | MCF-7 | breast: | |
2 | chr6:93649981..93651643-chr6:93653121..93655036,2 | MCF-7 | breast: | |
3 | chr6:93691182..93692729-chr6:93694302..93697274,2 | K562 | blood: | |
4 | chr6:93691182..93692729-chr6:93694302..93697274,2 | K562 | blood: | |
5 | chr6:93652357..93654023-chr6:93654782..93656970,2 | K562 | blood: | |
6 | chr6:93652357..93654023-chr6:93654782..93656970,2 | K562 | blood: | |
7 | chr12:54136317..54137172-chr6:93686043..93686596,2 | MCF-7 | breast: |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MANEA-5 | chr6:93690971-93691115 | NONHSAT114018 |
2 | lnc-MANEA-5 | chr6:93695712-93695847 | XLOC_005389 |
3 | lnc-MANEA-5 | chr6:93695711-93695847 | NONHSAT114018 |
4 | lnc-MANEA-5 | chr6:93689708-93689741 | XLOC_005389 |
5 | lnc-MANEA-5 | chr6:93689707-93689741 | NONHSAT114018 |
6 | lnc-MANEA-5 | chr6:93690972-93691115 | XLOC_005389 |
No data |
No data |
Variant related genes | Relation type |
---|---|
EDEM3 | miRNA target sites |
ZNF236 | miRNA target sites |
UPF2 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1338253 | chr6:93653226-93653227 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs193087653 | chr6:93653252-93653253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184917794 | chr6:93653274-93653275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs147281182 | chr6:93653328-93653329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1338252 | chr6:93653342-93653343 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs148711927 | chr6:93653382-93653383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529643889 | chr6:93653395-93653396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543895412 | chr6:93653399-93653400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563774430 | chr6:93653422-93653423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189762858 | chr6:93653443-93653444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs34848896 | chr6:93653574-93653575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142299215 | chr6:93653581-93653582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151324375 | chr6:93653597-93653598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34179217 | chr6:93653627-93653628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1572631 | chr6:93653651-93653652 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs1572630 | chr6:93653658-93653659 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs527609372 | chr6:93653666-93653667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140614106 | chr6:93653690-93653691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560787235 | chr6:93653721-93653722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192612096 | chr6:93653726-93653727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183863461 | chr6:93653731-93653732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569430321 | chr6:93653751-93653752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577079405 | chr6:93653782-93653783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376358639 | chr6:93653784-93653785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551591552 | chr6:93653824-93653825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113958905 | chr6:93653826-93653827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144351550 | chr6:93653886-93653887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79985546 | chr6:93653896-93653897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs117865246 | chr6:93653906-93653907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369997957 | chr6:93653913-93653914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575815436 | chr6:93653920-93653921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575038599 | chr6:93653985-93653986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537663775 | chr6:93653998-93653999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535401250 | chr6:93654005-93654006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544428205 | chr6:93654011-93654012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557456935 | chr6:93654093-93654094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577446186 | chr6:93654102-93654103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1572629 | chr6:93654129-93654130 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs113317959 | chr6:93654149-93654150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574826180 | chr6:93654151-93654152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559742367 | chr6:93654186-93654187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572236038 | chr6:93654201-93654202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188137067 | chr6:93654229-93654230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146613522 | chr6:93654249-93654250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529808220 | chr6:93654258-93654259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1572628 | chr6:93654302-93654303 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs34196370 | chr6:93654304-93654305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540982227 | chr6:93654308-93654309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563022840 | chr6:93654310-93654311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532281232 | chr6:93654353-93654354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuropathy | 19664229 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:93652400-93655200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr6:93653800-93654200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr6:93654200-93655600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr6:93655200-93656200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr6:93655600-93656000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr6:93655600-93656000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr6:93656200-93656400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr6:93672800-93673200 | Enhancers | Fetal Brain Female | brain |
9 | chr6:93674000-93675600 | Enhancers | Fetal Heart | heart |
10 | chr6:93677200-93677400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr6:93686000-93686400 | Enhancers | Small Intestine | intestine |
12 | chr6:93686000-93687800 | Enhancers | Duodenum Mucosa | Duodenum |
13 | chr6:93686400-93688800 | Weak transcription | Small Intestine | intestine |
14 | chr6:93686600-93687200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
15 | chr6:93687800-93689000 | Weak transcription | Duodenum Mucosa | Duodenum |
16 | chr6:93688400-93689400 | Enhancers | HUVEC | blood vessel |
17 | chr6:93688600-93689600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
18 | chr6:93688800-93689600 | Enhancers | Fetal Heart | heart |
19 | chr6:93688800-93689600 | Enhancers | Small Intestine | intestine |
20 | chr6:93689000-93689400 | Enhancers | Duodenum Mucosa | Duodenum |
21 | chr6:93689400-93694600 | Weak transcription | Duodenum Mucosa | Duodenum |
22 | chr6:93694600-93695800 | Enhancers | Duodenum Mucosa | Duodenum |
23 | chr6:93697800-93698000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
24 | chr6:93698000-93699000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |